CLINICAL_TRIALS
trial_result
· 2012-10-15
Clinical Trial Update: Evaluation of the Bioequivalence of a Combined Formulated Tablet [Phase 1]
Summary
A Phase 1 bioequivalence study update from ViiV Healthcare evaluating a combined formulated tablet; the study is reported as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED